Cempra Inc (NASDAQ:CEMP)
| 2.80 Delayed Data As of Oct 20 |  -0.10 / -3.45%Today’s Change | 2.55 Today|||52-Week Range 24.48 | 0.00% Year-to-Date |
Latest CEMP News | Press Releases
No recent news for Cempra Inc.
Today’s Trading
| Previous close | 2.90 |
| Today’s open | 2.90 |
| Day’s range | 2.70 - 2.90 |
| Volume | 667,281 |
| Average volume (3 months) | 796,931 |
| Market cap | $152.3M |
| Dividend yield | -- |
Data as of 3:59pm ET, 10/20/2017
Growth & Valuation
| Earnings growth (last year) | -11.96% |
| Earnings growth (this year) | +58.62% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -34.03% |
| P/E ratio | NM |
| Price/Sales | 7.82 |
| Price/Book | 0.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SMMTSummit Therapeutics ... | -0.31 | -2.59% |
| VRNAVerona Pharma PLC | -0.41 | -2.75% |
| NTECIntec Pharma Ltd | 0.00 | 0.00% |
| ACRXAcelRx Pharmaceutica... | +0.25 | +14.29% |
Data as of 4:00pm ET, 10/20/2017
Financials
| Next reporting date | November 1, 2017 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$118.0M |
| Net profit margin | -654.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director David Zaccardelli |
Chief Financial Officer & Executive Vice President Mark W. Hahn |
Corporate headquarters Chapel Hill, North Carolina |
Forecasts
